ENVI's concession for clinical investigations of short-term high-risk devices
This article was originally published in Clinica
Executive Summary
When the European Parliament’s lead committee voted on the compromise amendments to the European Commission’s proposed medical devices Regulation on 25 September, there were few changes to the articles that most concern industry when compared with the same articles in the 13 September proposed compromise amendments that had been put forward by ENVI rapporteur Dagmar Roth Behrendt.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.